Johnson & Johnson annual operating expenses
2009
2010
2011
2012
2013
2014
2022
2023
2024
2025
Johnson & Johnson Operating Expenses Growth & History (JNJ)
Johnson & Johnson's operating expenses was $38.34B for fiscal 2025.
View full Johnson & Johnson company overviewJohnson & Johnson annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-28 | $38.34B | −$1.76B | −4.39% |
| 2024 | 2024-12-29 | $40.10B | $3.50B | +9.57% |
| 2023 | 2023-12-31 | $36.60B | $2.22B | +6.45% |
| 2022 | 2023-01-01 | $34.38B | — | — |
| 2014 | 2014-12-28 | $30.00B | −$2.56B | −7.87% |
| 2013 | 2013-12-29 | $32.56B | $1.95B | +6.36% |
| 2012 | 2012-12-30 | $30.61B | −$294.0M | −0.95% |
| 2011 | 2012-01-01 | $30.91B | $5.81B | +23.15% |
| 2010 | 2011-01-02 | $25.09B | −$1.77B | −6.60% |
| 2009 | 2010-01-03 | $26.87B | — | — |
Johnson & Johnson quarterly operating expenses
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-28 | $10.09B | $680.0M | +7.23% |
| Q1 2026 | 2026-03-29 | $9.56B | — | — |
| Q4 2025 | 2025-12-28 | $11.01B | — | — |
| Q3 2025 | 2025-09-28 | $9.59B | — | — |
| Q2 2025 | 2025-06-29 | $9.40B | — | — |
| Q1 2015 | 2015-03-29 | $6.26B | −$744.0M | −10.61% |
| Q4 2014 | 2014-12-28 | $9.39B | $28.0M | +0.30% |
| Q3 2014 | 2014-09-28 | $6.01B | −$2.34B | −28.04% |
| Q2 2014 | 2014-06-29 | $7.58B | $213.0M | +2.89% |
| Q1 2014 | 2014-03-30 | $7.01B | −$460.0M | −6.16% |
| Q4 2013 | 2013-12-29 | $9.36B | $1.15B | +14.00% |
| Q3 2013 | 2013-09-29 | $8.36B | $729.0M | +9.55% |
| Q2 2013 | 2013-06-30 | $7.37B | −$1.31B | −15.07% |
| Q1 2013 | 2013-03-31 | $7.47B | $1.38B | +22.56% |
| Q4 2012 | 2012-12-30 | $8.21B | −$1.85B | −18.41% |
| Q3 2012 | 2012-09-30 | $7.63B | $1.35B | +21.42% |
| Q2 2012 | 2012-07-01 | $8.68B | $788.0M | +9.99% |
| Q1 2012 | 2012-04-01 | $6.09B | −$575.0M | −8.62% |
| Q4 2011 | 2012-01-01 | $10.06B | — | — |
| Q3 2011 | 2011-10-02 | $6.28B | $257.0M | +4.26% |
| Q2 2011 | 2011-07-03 | $7.89B | $1.56B | +24.75% |
| Q1 2011 | 2011-04-03 | $6.67B | — | — |
| Q3 2010 | 2010-10-03 | $6.03B | — | — |
| Q2 2010 | 2010-07-04 | $6.32B | — | — |
Johnson & Johnson operating expenses trends
Between the periods ended 2010-01-03 and 2025-12-28, Johnson & Johnson's operating expenses increased from $26.87B to $38.34B, a change of $11.47B. The latest reported quarter, Q2 2026, shows $10.09B.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Johnson & Johnson source filings ↗Community posts
Apollo reportedly nears $20 billion talks for J&J orthopedics business
Apollo ($APO) is in talks to acquire Johnson & Johnson’s ($JNJ) DePuy Synthes orthopedics business in a transaction that could be worth around $20 billion, Reuters reported, citing Bloomberg. The unit generated approximately $9.3 billion in ...